首页> 外文期刊>Cell Biochemistry and Biophysics >Comparison of the Therapeutic Effectiveness of Sustained Low-Efficiency Dialysis (SLED) with Continuous Blood Purification (CBP) in Critically Ill Patients
【24h】

Comparison of the Therapeutic Effectiveness of Sustained Low-Efficiency Dialysis (SLED) with Continuous Blood Purification (CBP) in Critically Ill Patients

机译:持续性低效率透析(SLED)与持续血液净化(CBP)在重症患者中的治疗效果比较

获取原文
获取原文并翻译 | 示例
           

摘要

The differences in therapeutic effectiveness between sustained low-efficiency dialysis (SLED) and continuous blood purification (CBP) were investigated. In order to assess the different treatment methods, 56 critically ill patients were divided into two groups, the CBP group and the SLED group. A comparison was made between all the biochemical indicators, in-hospital duration, hemodynamic parameters, acute physiology and chronic health evaluation (APACHE-II), the survival, and the mortality rates. After treatment, the levels of serum creatine kinase isozyme MB (CK-MB), creatine kinase, creatinine, glutamate-oxalacetate transaminase (AST), glutamate-pyruvate transaminase (ALT), APACHE II score on the 1st, 2nd, and 7th day in both the treatment groups were lower than that before the treatment (P < 0.05). There are no statistical differences in in-hospital duration, biochemical indicators, APACHE II score, hemodynamic parameters, the survival rate and the mortality rate between the two groups (P > 0.05). It was concluded that SLED has similar hemodynamic stability with CBP and the two methods have similar treatment effects in critically ill patients. However, we noticed that SLED can be relatively economical and convenient for critically ill patients in clinical practice.
机译:研究了持续低效透析(SLED)和连续血液净化(CBP)在治疗效果上的差异。为了评估不同的治疗方法,将56例重症患者分为两组,CBP组和SLED组。在所有生化指标,住院时间,血液动力学参数,急性生理学和慢性健康评估(APACHE-II),存活率和死亡率之间进行了比较。治疗后第1、2、7天,血清肌酸激酶同工酶MB(CK-MB),肌酸激酶,肌酐,谷氨酸-草酰乙酸转氨酶(AST),谷氨酸-丙酮酸转氨酶(ALT),APACHE II评分两个治疗组均低于治疗前(P <0.05)。两组之间的住院时间,生化指标,APACHE II评分,血液动力学参数,存活率和死亡率均无统计学差异(P> 0.05)。结论是,SLED具有与CBP相似的血液动力学稳定性,并且两种方法在危重患者中具有相似的治疗效果。但是,我们注意到SLED在临床实践中对于重症患者可能相对经济且方便。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号